Latest Biotechnology News

Vancouver, British Columbia--(Newsfile Corp. - June 3, 2019) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") announces that it has received a loan in the aggregate amount of $300,000 (the "Loan") pursuant to a loan agreement with the Company's Chairman and Chief Executive Officer, ...
Biotechnology, Medical/Pharmaceuticals
2019-06-03 8:00 AM ET | PreveCeutical Medical Inc.

Toronto, Ontario--(Newsfile Corp. - May 30, 2019) - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to announce that it has fulfilled its first shipment of a new Beleave-branded product line for the recreational market. The purchase order was placed by the Ontario Cannabis Store ("OCS").San ...
Biotechnology, Cannabis
2019-05-30 7:31 AM ET | Beleave Inc.

Newport Beach, California--(Newsfile Corp. - May 29, 2019) - Vivera Pharmaceuticals, Inc., a pharmaceutical company focused on non-addictive pain management, today announces its involvement with the Yale International Clinic. A collaboration between the Yale School of Medicine, the Instituto Tecnológico de Santo Domingo (INTEC), and sponsors including Vivera, the ...
Biotechnology, Health Care/Hospitals
2019-05-29 9:12 AM ET | Vivera Pharmaceuticals, Inc.

Toronto, Ontario--(Newsfile Corp. - May 23, 2019) - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is ready to move forward with the long-awaited expansion of its Hamilton facility after receiving approval from the Hamilton City Council.Last Tuesday, the Planning Committee unanimously authorized Beleave's request to rezone ...
Biotechnology, Cannabis
2019-05-23 8:12 AM ET | Beleave Inc.

Newport Beach, California--(Newsfile Corp. - May 22, 2019) - Vivera Pharmaceuticals, Inc., a pharmaceutical company focused on non-addictive pain management, today announces the appointment of Mr. Fred Jamee as the Company's Vice President of Regulatory and Compliance. Within this role, Mr. Jamee will ensure Vivera meets and exceeds all compliance ...
Biotechnology, Health Care/Hospitals
2019-05-22 9:04 AM ET | Vivera Pharmaceuticals, Inc.

Vancouver, British Columbia--(Newsfile Corp. - May 21, 2019) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces that the Company's research team at the University of Queensland has been granted the necessary approvals from a local hospital's Human Ethics Committee to acquire and use ...
Biotechnology, Medical/Pharmaceuticals
2019-05-21 8:00 AM ET | PreveCeutical Medical Inc.

Newport Beach, California--(Newsfile Corp. - May 16, 2019) - Vivera Pharmaceuticals, Inc., a pharmaceutical company focused on non-addictive pain management, today announces the appearance of its TVIA Kit™ in the hit video for the best-selling single "Boy and a Man" by Backstreet Boys member
Biotechnology, Health Care/Hospitals
2019-05-16 8:58 AM ET | Vivera Pharmaceuticals, Inc.

Vancouver, British Columbia--(Newsfile Corp. - May 16, 2019) - Biocure Technology Inc. (CSE: CURE) (OTCQB: BICTF) (formerly Gravis Energy Corp.) (the "Company" or "Biocure") is pleased to announce that Biocure Pharm Corp.("BPK"), a subsidiary of the Company has entered into an agreement with Pharos Vaccine Inc. for the development of ...
Biotechnology, Medical/Pharmaceuticals
2019-05-16 8:40 AM ET | Biocure Technology Inc.

Halifax, Nova Scotia--(Newsfile Corp. - May 16, 2019) - Antler Gold Inc. (TSXV: ANTL) ("
Biotechnology, Medical/Pharmaceuticals
2019-05-16 8:30 AM ET | Sona Nanotech Inc.

Newport Beach, California--(Newsfile Corp. - May 14, 2019) - Vivera Pharmaceuticals, Inc., a pharmaceutical company focused on non-addictive pain management, today announces the debut of the TVIA Kit™, a revolutionary medical product containing multiple drug delivery systems for patients who are seeking a non-addictive solution for pain. The three-part system ...
Biotechnology, Health Care/Hospitals
2019-05-14 9:15 AM ET | Vivera Pharmaceuticals, Inc.

Halifax, Nova Scotia--(Newsfile Corp. - May 9, 2019) - Sona Nanotech Inc.'s (CSE: SONA) mission to advance medical diagnostics took a step forward today with the announcement of a collaboration with the University of Birmingham in the UK to develop next generation nanorods for tissue imaging.The goal of the project, ...
Biotechnology, Medical/Pharmaceuticals
2019-05-09 8:30 AM ET | Sona Nanotech Inc.

Newport Beach, California--(Newsfile Corp. - May 2, 2019) - Vivera Pharmaceuticals, Inc., a pharmaceutical company focused on non-addictive pain management, today announced the appointment of Stephen J. McColgan, M.D., MBA, as its Chief Medical Officer. Dr. McColgan was one of the first surgeons to perform laparoscopic cholecystectomy, laparoscopic nissen ...
Biotechnology, Health Care/Hospitals
2019-05-02 9:15 AM ET | Vivera Pharmaceuticals, Inc.

Newport Beach, California--(Newsfile Corp. - April 30, 2019) - Vivera Pharmaceuticals, Inc., a pharmaceutical company focused on non-addictive pain management, today announces the debut of TABMELT®, a sublingual drug delivery system that Vivera has exclusively licensed for the specific use for pharmaceutical cannabinoids, including cannabidiol (CBD), a non-psychoactive compound derived ...
Biotechnology, Health Care/Hospitals
2019-04-30 12:00 PM ET | Vivera Pharmaceuticals, Inc.

New York, New York--(Newsfile Corp. - April 24, 2019) - Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company, announced today its technology partner Mannin Research will be attending ARVO 2019 the Annual Meeting of the Association for Research in Vision and Ophthalmology from April 28 to May 2, ...
Biotechnology
2019-04-24 8:00 AM ET | Q BioMed Inc.

Toronto, Ontario--(Newsfile Corp. - April 18, 2019) - World Class Extractions Inc. (CSE: PUMP) ("World Class" or the "Company") is pleased to announce that it has retained the services of Mackie Research Capital Corporation ("Mackie Research") to act as financial advisor to the Company. Mackie Research will provide advisory ...
Biotechnology, Cannabis
2019-04-18 8:30 AM ET | World Class Extractions Inc.

Vancouver, British Columbia--(Newsfile Corp. - April 17, 2019) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") announces that the Company's research collaboration with UniQuest and The University of Queensland ("UQ") has led to the filing of two new patent applications for cyclic peptides ...
Biotechnology, Medical/Pharmaceuticals
2019-04-17 10:35 AM ET | PreveCeutical Medical Inc.

Vancouver, British Columbia--(Newsfile Corp. - April 15, 2019) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces the Company's research team at the University of Queensland has filed an application to a local hospital's Human Ethics Committee (the "Human Ethics Committee") to acquire ...
Biotechnology, Medical/Pharmaceuticals
2019-04-15 8:30 AM ET | PreveCeutical Medical Inc.

New York, New York--(Newsfile Corp. - April 12, 2019) - Genprex Inc. (NASDAQ: GNPX) announces the availability of a NetworkNewsAudio broadcast titled, "Potential Blockbuster Gene Therapy Programs to Watch in 2019."To hear the NetworkNewsWire Audio version, visit: http://nnw.fm/j1WMsTo read the full editorial, visit:
Biotechnology, Health Care/Hospitals
2019-04-12 9:00 AM ET | Genprex, Inc.

New York, New York--(Newsfile Corp. - April 11, 2019) - Genprex Inc. (NASDAQ: GNPX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company for private and public entities.To view the full publication, titled "Potential Blockbuster Gene Therapy Programs to Watch in ...
Biotechnology, Health Care/Hospitals
2019-04-11 8:30 AM ET | Genprex, Inc.

Marks the first time a company has identified biomarkers that hold the potential to stratify this subset of patientsStudy examined 1,953 significant autistic biomarkers, resulting in 2 significant markers tied to expressed genes and pathways responsible for speech developmentBiomarkers in the nonverbal subset were distinct from children with typical speech ...
Biotechnology
2019-04-10 8:30 AM ET | Q BioMed Inc.

Vancouver, British Columbia--(Newsfile Corp. - April 10, 2019) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce further positive results from the preliminary screening of key peptides from its scorpion venom-derived peptide research and development program (the "Peptide Program"), that is ...
Biotechnology, Medical/Pharmaceuticals
2019-04-10 8:30 AM ET | PreveCeutical Medical Inc.

Vancouver, British Columbia--(Newsfile Corp. - April 8, 2019) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces that it has obtained a default judgement against JCN Capital Corp. ("JCN") in connection with a Supreme Court of British Columbia action (the "Action"). The Action ...
Biotechnology, Medical/Pharmaceuticals
2019-04-08 9:35 AM ET | PreveCeutical Medical Inc.

Vancouver, British Columbia--(Newsfile Corp. - April 4, 2019) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces that, at the request of the Investment Industry Regulatory Organization of Canada, it hereby retracts certain statements regarding estimated annual production, valuation and harvest quantities from the ...
Biotechnology, Medical/Pharmaceuticals
2019-04-04 5:09 PM ET | PreveCeutical Medical Inc.

Vancouver, British Columbia--(Newsfile Corp. - April 4, 2019) - Asterion Cannabis Inc. (P.ASTR) ("Asterion") and PreveCeutical Medical Inc. ("PreveCeutical") (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), announce today that Asterion's wholly-owned Australian subsidiary, Asterion Australia Pty Ltd, has been awarded Major Project Status for Asterion's Toowoomba Medicinal Cannabis Project (the "Toowoomba ...
Biotechnology, Medical/Pharmaceuticals
2019-04-04 2:40 PM ET | PreveCeutical Medical Inc.

New York, New York--(Newsfile Corp. - March 29, 2019) - Genprex Inc. (NASDAQ: GNPX) announces the availability of a NetworkNewsAudio publication titled, "Advanced Medical Technologies Provides Unprecedented Targeting in Cancer Therapy."To hear the NetworkNewsWire Audio version, visit: http://nnw.fm/XRt4dTo read the full editorial, visit:
Biotechnology, Health Care/Hospitals
2019-03-29 9:00 AM ET | Genprex, Inc.